PMID: 8614890Apr 1, 1996Paper

Massive asymmetric virginal breast hypertrophy

Southern Medical Journal
D T NetscherR Laucirica

Abstract

Massive unilateral virginal breast hypertrophy in a 13-year-old girl was treated by right breast reduction, with removal of 2,968 g of breast tissue. A year later, the patient had enlargement of the left breast, and contralateral reduction mammoplasty was done. Two-year follow-up has shown no further enlargement. This case lends itself to a discussion with regard to the differential diagnosis of unilateral breast hypertrophy in adolescence. True virginal gigantomastia is relatively rare. Surgical reduction mammoplasty plays a pivotal role in the treatment of massive virginal breast hypertrophy.

Citations

Dec 15, 2010·International Journal of Surgery·Peter F KoltzJohn A Girotto
Jun 29, 1999·Pediatric Clinics of North America·L S Neinstein
Sep 16, 2000·Pediatric Dermatology·P M O'Hare, I J Frieden
May 28, 2011·Plastic and Reconstructive Surgery·Ian C HoppeMark S Granick
Jul 31, 2013·Journal of Pediatric and Adolescent Gynecology·Amy S XueLior Heller
Aug 12, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·A A Al-SaifM M Al-Qattan
Feb 23, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Linda FiumaraElizabeth Courtauld
Dec 7, 2007·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Anne DanceyF Peart
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·J SkillmanH Hamed
May 16, 2001·Annals of Plastic Surgery·S B BakerD LaRossa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Dermatology
P M O'Hare, I J Frieden
American Journal of Surgery
Gottfried WechselbergerHildegunde Piza-Katzer
Journal of Paediatrics and Child Health
Ildi H Koves, Margaret Zacharin
European Journal of Obstetrics, Gynecology, and Reproductive Biology
P SagotP Lopes
© 2021 Meta ULC. All rights reserved